PMEF
Point72 Middle East FZE Portfolio holdings
AUM
$1.44B
1-Year Return
6.39%
This Quarter Return
+2.45%
1 Year Return
+6.39%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.8B
AUM Growth
+$33.2M
(+1.9%)
Cap. Flow
+$1.15M
Cap. Flow
% of AUM
0.06%
Top 10 Holdings %
Top 10 Hldgs %
16.59%
Holding
1,653
New
573
Increased
246
Reduced
114
Closed
659
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
+$52.6M |
| 2 |
Union Pacific
UNP
|
+$23.9M |
| 3 |
Booking.com
BKNG
|
+$21.2M |
| 4 |
Boston Scientific
BSX
|
+$20.7M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$19.9M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$121M |
| 2 |
Cigna
CI
|
+$25.8M |
| 3 |
Lowe's Companies
LOW
|
+$25M |
| 4 |
Philip Morris
PM
|
+$24.2M |
| 5 |
Visa
V
|
+$24.1M |
Sector Composition
| 1 | Technology | 17.37% |
| 2 | Healthcare | 14.63% |
| 3 | Consumer Discretionary | 14.54% |
| 4 | Financials | 13.37% |
| 5 | Industrials | 11.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
701
Gates Industrial
GTES
$6.48B
| $98.6K | ﹤0.01% |
7,316
+5,851
| +399% | +$78.9K |
|
702
Cannae Holdings
CNNE
$1.11B
| $93.6K | ﹤0.01% |
+4,633
| New | +$93.6K |
|
703
Comtech Telecommunications
CMTL
$67.9M
| $93.4K | ﹤0.01% |
+10,214
| New | +$93.4K |
|
704
Fulgent Genetics
FLGT
$683M
| $92.5K | ﹤0.01% |
2,497
+1,789
| +253% | +$66.2K |
|
705
Kezar Life Sciences
KZR
$29.4M
| $91.9K | ﹤0.01% |
3,752
+1,324
| +55% | +$32.4K |
|
706
FS KKR Capital
FSK
$5B
| $91.9K | ﹤0.01% |
+4,789
| New | +$91.9K |
|
707
Pathward Financial
CASH
$1.75B
| $91.1K | ﹤0.01% |
+1,964
| New | +$91.1K |
|
708
BioCryst Pharmaceuticals
BCRX
$1.7B
| $89.8K | ﹤0.01% |
12,755
-2,300
| -15% | -$16.2K |
|
709
Woodward
WWD
$14.2B
| $87.6K | ﹤0.01% |
737
-7,026
| -91% | -$835K |
|
710
1st Source
SRCE
$1.57B
| $87.6K | ﹤0.01% |
+2,088
| New | +$87.6K |
|
711
Playboy, Inc. Common Stock
PLBY
$190M
| $86.3K | ﹤0.01% |
+51,374
| New | +$86.3K |
|
712
Telos
TLS
$464M
| $85.2K | ﹤0.01% |
33,285
+32,389
| +3,615% | +$82.9K |
|
713
Upland Software
UPLD
$70.5M
| $84.1K | ﹤0.01% |
23,349
+21,927
| +1,542% | +$78.9K |
|
714
Blue Owl Capital
OBDC
$7.25B
| $83.5K | ﹤0.01% |
+6,222
| New | +$83.5K |
|
715
Openlane
KAR
$3.14B
| $83.1K | ﹤0.01% |
+5,458
| New | +$83.1K |
|
716
Heidrick & Struggles
HSII
$1.04B
| $81.4K | ﹤0.01% |
3,074
+823
| +37% | +$21.8K |
|
717
Workhorse Group
WKHS
$18.3M
| $80.5K | ﹤0.01% |
369
+194
| +111% | +$42.3K |
|
718
Veru
VERU
$50.8M
| $80.4K | ﹤0.01% |
+6,759
| New | +$80.4K |
|
719
Ares Capital
ARCC
$15.7B
| $79K | ﹤0.01% |
+4,205
| New | +$79K |
|
720
Nektar Therapeutics
NKTR
$924M
| $78.9K | ﹤0.01% |
+9,143
| New | +$78.9K |
|
721
Parsons
PSN
$7.96B
| $78.9K | ﹤0.01% |
+1,638
| New | +$78.9K |
|
722
Heron Therapeutics
HRTX
$199M
| $78.7K | ﹤0.01% |
+67,821
| New | +$78.7K |
|
723
Universal Corp
UVV
$1.37B
| $78.2K | ﹤0.01% |
+1,566
| New | +$78.2K |
|
724
Microvast
MVST
$910M
| $77.8K | ﹤0.01% |
48,611
+41,489
| +583% | +$66.4K |
|
725
N-able
NABL
$1.56B
| $75.4K | ﹤0.01% |
+5,235
| New | +$75.4K |
|